Clinical trial

Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer

NCT01199367

Study summary

ClinicalTrials.gov

Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention KW-2450 in combination with lapatinib and letrozole Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2010-12-01

PhasePHASE1

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

KW-2450 in combination with lapatinib and letrozoleDRUG

Sponsors & collaborators

Kyowa Kirin Co., Ltd.lead sponsor

Kyowa Hakko Kirin Pharma, Inc.collaborator

Mapped research locations

HoustonTexas, United States1 Los AngelesCalifornia, United States1 Long BeachCalifornia, United States1 Farmington HillsMichigan, United States1 Deerfield BeachFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01199367 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.